521 related articles for article (PubMed ID: 17126339)
1. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
3. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.
Merviel P; Antoine JM; Mathieu E; Millot F; Mandelbaum J; Uzan S
Fertil Steril; 2004 Jul; 82(1):119-25. PubMed ID: 15236999
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization.
Lisi F; Rinaldi L; Fishel S; Caserta D; Lisi R; Campbell A
Fertil Steril; 2005 Feb; 83(2):309-15. PubMed ID: 15705367
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
8. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
9. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is present during mouse in vitro oocyte maturation.
De Matos DG; Miller K; Scott R; Tran CA; Kagan D; Nataraja SG; Clark A; Palmer S
Fertil Steril; 2008 Dec; 90(6):2367-75. PubMed ID: 18222433
[TBL] [Abstract][Full Text] [Related]
11. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
12. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
Selman H; Pacchiarotti A; El-Danasouri I
Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
[TBL] [Abstract][Full Text] [Related]
13. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization.
Kovacs P; Kovats T; Kaali SG
Fertil Steril; 2010 Feb; 93(2):475-9. PubMed ID: 19200991
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
Fábregues F; Creus M; Peñarrubia J; Manau D; Vanrell JA; Balasch J
Fertil Steril; 2006 Apr; 85(4):925-31. PubMed ID: 16580376
[TBL] [Abstract][Full Text] [Related]
15. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
[TBL] [Abstract][Full Text] [Related]
16. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G
Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994
[TBL] [Abstract][Full Text] [Related]
17. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
Levi-Setti PE; Cavagna M; Bulletti C
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
[TBL] [Abstract][Full Text] [Related]
18. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
[TBL] [Abstract][Full Text] [Related]
19. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
